切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2025, Vol. 22 ›› Issue (10) : 988 -993. doi: 10.3877/cma.j.issn.1672-6448.2025.10.013

综述

超声剪切波频散成像技术在肝脏疾病中的应用及研究进展
胡萱, 陈婷(), 雷志锴   
  1. 310000 杭州,浙江中医药大学附属第一医院(浙江省中医院)超声医学科
  • 收稿日期:2025-04-18 出版日期:2025-10-01
  • 通信作者: 陈婷

Shear wave dispersion imaging in liver diseases: applications and research advances

Xuan Hu, Ting Chen(), Zhikai Lei   

  • Received:2025-04-18 Published:2025-10-01
  • Corresponding author: Ting Chen
引用本文:

胡萱, 陈婷, 雷志锴. 超声剪切波频散成像技术在肝脏疾病中的应用及研究进展[J/OL]. 中华医学超声杂志(电子版), 2025, 22(10): 988-993.

Xuan Hu, Ting Chen, Zhikai Lei. Shear wave dispersion imaging in liver diseases: applications and research advances[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2025, 22(10): 988-993.

表1 SWD技术在MAFLD中的临床研究
参考文献 研究设计(例数) 研究对象 诊断标准 超声设备 参数(单位) 测量方法 结果/结论
李亚雪等[13] 前瞻性(255) 138例MAFLD患者及117例健康成人 常规超声 Canon Aplio i900 SWDS(m·s-1·kHz-1 测量部位:肝右叶S5段
取样框大小:3 cm×3 cm
ROI:肝包膜下1 cm
重复测量5次后取中位数
轻度、中度、重度MAFLD患者的平均SWDS值分别为(14.37±0.95)、(16.90±0.87)、(17.46±0.88)m·s-1·kHz-1,SWD诊断不同程度MAFLD的AUC为0.791~0.992,显示出较高的诊断效能
Gao等[14] 前瞻性(21) 接受MRI-PDFF的成年患者 MRI-PDFF Canon Aplio i800 SWDS(m·s-1·kHz-1 测量部位:肋间
ROI:1 cm×1 cm
重复测量10次后取平均值
正常肝脏、MAFLD患者SWDS值分别为(10±1.53)、(12.33±0.87)m·s-1·kHz-1,与正常肝脏患者相比,MAFLD患者SWDS值显著升高
Platz Batista等[15] 回顾性(15) 可疑MAFLD的患者 MRI-PDFF Canon Aplio i800 SWDS(m·s-1·kHz-1 ROI:1 cm×1 cm
重复5~6次后取平均值
在PDFF序列中,3例患者表现为轻度脂肪变性,1例表现为中度脂肪变性,11例未见脂肪变性。以PDFF为金标准,当SWDS以18.5 m·s-1·kHz-1为截断值时,可正确识别4例肝脏脂肪变性患者。SWD评估MAFLD的敏感度和特异度分别为75%和90.9%
汪许红等[16] 回顾性(186) MAFLD患者 常规超声 东芝 Aplio i800 SWDS(m·s-1·kHz-1 测量部位:离肝包膜2~3 cm处肝右叶
ROI:2 cm×2 cm
重复测量5次后取平均值
SWD对≥S1期和≥S2期脂肪变性的诊断能力较差(AUC分别为0.641和0.621,P<0.01),对≥S3期脂肪变性的诊断价值不高
D'Hondt等[17] 前瞻性(48) 接受腹部MRI检查的患儿 MRI-PDFF Philips Epiq-7G SWDS(m·s-1·kHz-1 测量部位:右肝
ROI:1 cm×1 cm
测量6次后取平均值
SWDS值在S0~S3期脂肪变性中分别为(13.56±2.64)、(15.68±1.93)、(13.14±0.95)、(15.39±3.99)m·s-1·kHz-1,S0期与S1~S3期、S0~S1期与S2~S3期差异均无统计学意义(P>0.05)
Pirmoazen等[18] 前瞻性(35) 疑似或确诊的MAFLD患者 MRI-PDFF Philips Epiq-7 SWDS(m·s-1·kHz-1 测量部位:肝包膜下2 cm 以MRI-PDFF≥6.4%为诊断MAFLD的阈值,正常肝脏与MAFLD的SWDS值分别为(12.94±1.44)、(13.30±1.59)m·s-1·kHz-1,二者差异无统计学意义(P>0.05)
1
Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease[J]. Hepatology, 2023, 77(5): 1797-1835.
2
中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版)[J]. 中华肝脏病杂志, 2018, 26(3): 195-203.
3
Ferraioli G, Barr RG, Berzigotti A, et al. WFUMB guideline/guidance on liver multiparametric ultrasound: part 1. Update to 2018 guidelines on liver ultrasound elastography[J]. Ultrasound Med Biol, 2024, 50(8): 1071-1087.
4
Abboud Y, Gaddam S. The role of endoscopic ultrasound-guided shear wave elastography in pancreatic diseases[J]. Diagnostics (Basel), 2024, 14(20): 2329.
5
Ye J, Wang W, Feng S, et al. Precise fibrosis staging with shear wave elastography in chronic hepatitis B depends on liver inflammation and steatosis[J]. Hepatol Int, 2020, 14(2): 190-201.
6
Chen S, Urban MW, Pislaru C, et al. Shearwave dispersion ultrasound vibrometry (SDUV) for measuring tissue elasticity and viscosity[J]. IEEE Trans Ultrason Ferroelectr Freq Control, 2009, 56(1): 55-62.
7
Zhang XQ, Zheng RQ, Jin JY, et al. US shear-wave elastography dispersion for characterization of chronic liver disease[J]. Radiology, 2022, 305(3): 597-605.
8
Grant EG. Calibrated US for quantification of fatty liver disease[J]. Radiology, 2023, 306(3): e221540.
9
Barry CT, Mills B, Hah Z, et al. Shear wave dispersion measures liver steatosis.[J]. Ultrasound Med Biol, 2012, 38(2): 175-182.
10
Barry CT, Hazard C, Hah Z, et al. Shear wave dispersion in lean versus steatotic rat livers[J]. J Ultrasound Med, 2015, 34(6): 1123-1129.
11
Bedossa P, FLIP Pathology Consortium. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease[J]. Hepatology, 2014, 60(2):565-575.
12
Berzigotti A, Tsochatzis E, Boursier J, et al. EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update[J]. J. Hepatol, 2021, 75(3): 659-689.
13
李亚雪, 薛红元, 武晓静, 等. 超声SWE、SWD技术在代谢功能障碍相关性脂肪肝病中的初步研究[J]. 中国超声医学杂志, 2022, 38(10): 1128-1131.
14
Gao J, Lee R, Trujillo M. Reliability of performing multiparametric ultrasound in adult livers[J]. J Ultrasound Med, 2022, 41(3): 699-711.
15
Platz Batista da Silva N, Scharf G, Lürken L, et al. Different ultrasound shear wave elastography techniques as novel imaging-based approaches for quantitative evaluation of hepatic steatosis-preliminary findings[J]. Tomography, 2023, 9(2): 681-692.
16
汪许红, 张盛敏, 杨敏, 等. 新型定量超声技术在非酒精性脂肪肝患者肝脏脂肪变性定量中的应用[J]. 中国超声医学杂志, 2021, 37(11): 1253-1257.
17
D'Hondt A, Rubesova E, Xie H, et al. Liver fat quantification by ultrasound in children: a prospective study[J]. AJR Am J Roentgenol, 2021, 217(4): 996-1006.
18
Pirmoazen AM, Khurana A, Loening AM, et al. Diagnostic performance of 9 quantitative ultrasound parameters for detection and classification of hepatic steatosis in nonalcoholic fatty liver disease[J]. Invest Radiol, 2022, 57(1): 23-32.
19
中华医学会肝病学分会. 代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)[J]. 中华肝脏病杂志, 2024, 32(5): 418-434.
20
Kim Y, Hwang J, Bae SH, et al. Clinical feasibility of shear wave dispersion slope for noninvasive diagnosis of nonalcoholic steatohepatitis in patients with morbid obesity: preliminary results using US shear wave elastography[J]. Ultrasound Q, 2022, 38(2): 149-154.
21
Jang JK, Lee ES, Seo JW, et al. Two-dimensional shear-wave elastography and US attenuation imaging for nonalcoholic steatohepatitis diagnosis: a cross-sectional, multicenter study[J]. Radiology, 2022, 305(1): 118-126.
22
Funada K, Kusano Y, Gyotoku Y, et al. Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index[J]. World J Gastroenterol, 2023, 29(23): 3703-3714.
23
Zhao Y, Qiu C, Dong Y, et al. Technical acoustic measurements combined with clinical parameters for the differential diagnosis of nonalcoholic steatohepatitis[J]. Diagnostics, 2023, 13(9): 1547.
24
Su PY, Su WW, Wu LS, et al. Reduction of shear wave elastography but not shear wave dispersion after successful hepatitis C treatment with direct-acting antiviral agents[J]. J Ultrasound Med, 2021, 40(9): 1919-1926.
25
Soh EG, Lee YH, Kim YR, et al. Usefulness of 2D shear wave elastography for the evaluation of hepatic fibrosis and treatment response in patients with autoimmune hepatitis[J]. Ultrasonography, 2022, 41(4): 740-749.
26
Song SJ, Kim YR, Lee YH, et al. Potential role of two-dimensional shear wave elastography, including liver stiffness measurement and dispersion slope, for management of chronic hepatitis B[J]. Ultrasonography, 2024, 43(5): 384-392.
27
罗月, 薛宏伟, 王培军. 应重视肝纤维化的影像学研究进展及应用[J]. 中华医学杂志, 2019, 99(7): 481-483.
28
Ferraioli G, Maiocchi L, Dellafiore C, et al. Performance and cutoffs for liver fibrosis staging of a two-dimensional shear wave elastography technique[J]. Eur J Gastroenterol Hepatol, 2021, 33(1): 89-95.
29
李雪齐, 程广文, 梁静, 等. 剪切波频散成像和弹性成像联合血清学指标的预测模型在肝纤维化分期中的应用价值[J]. 中华医学杂志, 2023, 103(29): 2246-2251.
30
温莉, 张涛, 王坤. 超声剪切波频散成像术前评估肝细胞肝癌患者肝纤维化的初步临床研究[J]. 河北医科大学学报, 2023, 44(8): 956-960.
31
Wang K, Yu D, Li G, et al. Comparison of the diagnostic performance of shear wave elastography with shear wave dispersion for pre-operative staging of hepatic fibrosis in patients with hepatocellular carcinoma[J]. Eur J Radiol, 2022, 154: 110459.
32
中华医学会消化病学分会. 中国肝硬化临床诊治共识意见[J]. 中华消化杂志, 2023, 43(4): 227-247.
33
王佳音, 周洪雨, 李庭红, 等. 超声剪切波频散成像对代偿期肝硬化高风险食管胃静脉曲张的诊断价值[J]. 临床肝胆病杂志, 2022, 38(7): 1554-1560.
34
Sun X, Zhang L, Jiang L, et al. Shear wave dispersion slope measured with shear wave dispersion imaging is associated with variceal hemorrhage in cirrhotic patients[J]. Diagnostics (Basel), 2022, 12(12): 2909.
35
Hirooka M, Koizumi Y, Nakamura Y, et al. Spleen stiffness in patients with chronic liver disease evaluated by 2‐D shear wave elastography with ultrasound multiparametric imaging[J]. Hepatol Res, 2023, 53(2): 93-103.
36
Chernyak V, Fowler KJ, Kamaya A, et al. Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients[J]. Radiology, 2018, 289(3): 816-830.
37
Dong Y, Qiu Y, Zhang Q, et al. Preliminary clinical experience with shear wave dispersion imaging for liver viscosity in preoperative diagnosis of focal liver lesions[J]. Z Gastroenterol, 2020, 58(9): 847-854.
38
王坤, 朱宇莉, 陈凯玲, 等. 剪切波频散成像鉴别诊断肝肿瘤良恶性的初步应用[J]. 中华超声影像学杂志, 2022, 31(6): 518-524.
39
Wang K, Zhu Y, Bao J, et al. Clinical application of preoperative shear wave dispersion for prediction of post liver failure in patients with hepatocellular carcinoma after hepatectomy[J]. Clin Hemorheol Microcirc, 2023, 85(3): 223-234.
40
Xiong Y, Xin Y, Liu F, et al. Efficacy of shear wave dispersion imaging for viscoelastic assessment of the liver in acute graft-versus-host disease rats[J]. Quant Imaging Med Surg, 2022, 12(11): 5044-5055.
41
Cetinic I, De Lange C, Boström H, et al. Shear wave elastography and shear wave dispersion correlated to biopsy at the scheduled follow‐up of pediatric liver grafts[J]. Pediatr Transplant, 2023, 27(7): e14591.
42
Nakayama R, Takaya Y, Nakamura K, et al. Efficacy of shear wave elastography for assessment of liver function in patients with heart failure[J]. ESC Heart Fail, 2021, 8(3): 1751-1758.
43
Misaka T, Yoshihisa A, Ichijo Y, et al. Prognostic significance of spleen shear wave elastography and dispersion in patients with heart failure: the crucial role of cardio-splenic axis[J]. Clin Res Cardiol, 2023, 112(7): 942-953.
44
Urabe C, Takaya Y, Nakayama R, et al. Shear wave dispersion slope of the liver can predict adverse outcomes in patients with pulmonary hypertension[J]. Int Heart J, 2023, 64(2): 230-236.
45
Sugiura R, Kuwatani M, Nishida M, et al. Significance of shear wave dispersion slope values before versus after biliary drainage in patients with obstructive jaundice: a single-center prospective observational cohort study[J]. Ultrasound Q, 2023, 39(3): 152-157.
46
Mathur A, Ozkaya E, Rosberger S, et al. Concordance of vibration-controlled transient elastography and magnetic resonance elastography for fibrosis staging in patients with metabolic dysfunction-associated steatotic liver disease[J]. Eur Radio, 2025, 35(10): 6507-6515.
No related articles found!
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?